Publications by authors named "Eric Neau"

Claim this Profile
C
Calprotectin is a contributor to and potential therapeutic target for vascular calcification in chronic kidney disease.
Ana Amaya-Garrido, Manon Brunet, Bénédicte Buffin-Meyer, Alexis Piedrafita, Lucile Grzesiak, Eric Neau

Sci Transl Med· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mapping of the amniotic fluid proteome of fetuses with congenital anomalies of the kidney and urinary tract identifies plastin 3 as a protein involved in glomerular integrity.
Camille Fédou, Mylène Camus, Ophélie Lescat, Guylène Feuillet, Ilka Mueller, Eric Neau

J Pathol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Amniotic fluid peptides predict postnatal kidney survival in developmental kidney disease.
Julie Klein, Bénédicte Buffin-Meyer, Franck Boizard, Nabila Moussaoui, Ophélie Lescat, Eric Neau

Kidney Int· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The low affinity p75 neurotrophin receptor is down-regulated in congenital anomalies of the kidney and the urinary tract: Possible involvement in early nephrogenesis.
Camille Fédou, Ophélie Lescat, Guylène Feuillet, Marie Buléon, Eric Neau

Biochem Biophys Res Commun· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Connectivity mapping of glomerular proteins identifies dimethylaminoparthenolide as a new inhibitor of diabetic kidney disease.
Julie Klein, Cécile Caubet, Mylène Camus, Manousos Makridakis, Colette Denis, Eric Neau

Sci Rep· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systems biology combining human- and animal-data miRNA and mRNA data identifies new targets in ureteropelvic junction obstruction.
Theofilos Papadopoulos, Audrey Casemayou, Eric Neau, Benjamin Breuil, Cécile Caubet

BMC Syst Biol· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
miRNAs in urine: a mirror image of kidney disease?
Theofilos Papadopoulos, Julie Belliere, Jean-Loup Bascands, Eric Neau, Julie Klein

Expert Rev Mol Diagn· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Kinin B1 receptor antagonism is equally efficient as angiotensin receptor 1 antagonism in reducing renal fibrosis in experimental obstructive nephropathy, but is not additive.
Antoine Huart, Julie Klein, Julien Gonzalez, Bénédicte Buffin-Meyer, Eric Neau

Front Pharmacol· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blockade of the kinin B1 receptor ameloriates glomerulonephritis.
Julie Klein, Julien Gonzalez, Stéphane Decramer, Flavio Bandin, Eric Neau

J Am Soc Nephrol· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Delayed treatment with plasminogen activator inhibitor-1 decoys reduces tubulointerstitial fibrosis.
Julien Gonzalez, Julie Klein, Sharmila D Chauhan, Eric Neau, Denis Calise

Exp Biol Med (Maywood)· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular determinants of LPS-induced acute renal inflammation: Implication of the kinin B1 receptor.
Jean-Loup Bascands, Magdalena Bachvarova, Eric Neau, Joost P Schanstra, Dimcho Bachvarov

Biochem Biophys Res Commun· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LPA1 receptor activation promotes renal interstitial fibrosis.
Jean-Philippe Pradère, Julie Klein, Sandra Grès, Charlotte Guigné, Eric Neau

J Am Soc Nephrol· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Renal gene expression profiling using kinin B1 and B2 receptor knockout mice reveals comparable modulation of functionally related genes.
Dimcho Bachvarov, Magdalena Bachvarova, Rainelli Koumangaye, Julie Klein, João Bosco Pesquero, Eric Neau

Biol Chem· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The protective effect of angiotensin converting enzyme inhibition in experimental renal fibrosis in mice is not mediated by bradykinin B2 receptor activation.
Joost P Schanstra, Johan Duchene, Laurence Desmond, Eric Neau, Denis Calise

Thromb Haemost· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vivo bradykinin B2 receptor activation reduces renal fibrosis.
Joost P Schanstra, Eric Neau, Pascale Drogoz, Miguel A Arevalo Gomez, José Miguel Lopez Novoa

J Clin Invest· August 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Induction of B1 receptors in streptozotocin diabetic rats: possible involvement in the control of hyperglycemia-induced glomerular Erk 1 and 2 phosphorylation.
Marilyne Mage, Christiane Pécher, Eric Neau, Eric Cellier, Marina L Dos Reiss

Can J Physiol Pharmacol· April 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Induction of functional bradykinin b(1)-receptors in normotensive rats and mice under chronic Angiotensin-converting enzyme inhibitor treatment.
Maria E Marin-Castaño, Joost P Schanstra, Eric Neau, Françoise Praddaude, Christiane Pecher

Circulation· February 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis